Calcium infusion and left ventricular diastolic function in patients with chronic renal failure. 1998

V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
Department of Medicine, Tampere University Hospital, Finland.

BACKGROUND Left ventricular (LV) function is sensitive to disorders in calcium metabolism. Most previous reports have focused on the effects of calcium on systolic performance. We studied the acute effect of calcium infusion on LV diastolic function in patients with moderate to severe chronic renal failure (CRF) and secondary hyperparathyroidism (SHP). METHODS We infused calcium gluconate at a constant rate of 45 mumol/kg/h to 14 patients with severe to moderate CRF and SHP. Our aim was to reach slightly supranormal levels of serum ionized calcium (1.35-1.45 mmol/l). LV diastolic function was assessed by pulsed Doppler echocardiography before and after the calcium infusion. The echocardiographic indices were compared to those of 14 age- and sex-matched healthy controls. RESULTS Before calcium infusion the patients had significantly greater LV dimensions than the controls, but there was no differences in the diastolic indices. During calcium infusion, serum ionized calcium increased from 1.18 +/- 0.03 to 1.40 +/- 0.03 mmol/l (P < 0.0001) and plasma intact PTH decreased from 38.6 +/- 5.6 to 9.0 +/- 2.2 pmol/l (P < 0.0001). Calcium infusion did not affect the LV dimensions or fractional shortening. The peak early diastolic velocity (Emax) decreased and peak late diastolic velocity (Amax) increased, and their relationship decreased significantly (1.552 +/- 0.586 vs 1.414 +/- 0.535 m/s, P = 0.03). These changes reflect impairment of LV diastolic function. CONCLUSIONS Induction of acute hypercalcaemia by calcium infusion impairs LV diastolic function in patients with CRF and SHP.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
April 2004, Kidney international,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
February 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
January 2003, Terapevticheskii arkhiv,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
January 2007, Klinicheskaia meditsina,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
April 2003, Polskie Archiwum Medycyny Wewnetrznej,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
January 1995, Nephron,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
December 1976, British heart journal,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
June 2005, Diabetic medicine : a journal of the British Diabetic Association,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
February 1991, Annales de cardiologie et d'angeiologie,
V K Virtanen, and H H Saha, and K W Groundstroem, and E S Seppälä, and A I Pasternack
April 2004, Echocardiography (Mount Kisco, N.Y.),
Copied contents to your clipboard!